| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MYO5C | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | MAP3K9 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | LEFTY2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | FAM122C | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | HIST2H2AA3 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | MRPL14 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | OGDHL | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | OR8I2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | CDON | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | TMEM203 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
